The anticonvulsant effect of carbonic anhydrase inhibitors in mice — A noradrenergic mechanism of action

This publication has 10 references indexed in Scilit:

• Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline
  Journal of Pharmacy and Pharmacology, 1971
• Effects ofl-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs
  Cellular and Molecular Life Sciences, 1971
• Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain
  European Journal of Pharmacology, 1971
• 4, 4, 6-Trimethyl-3, 4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-β-hydroxylation in vivo
  Biochemical Pharmacology, 1971
• Studies on central and peripheral noradrenaline neurons using a new dopamine-β-hydroxylase inhibitor
  European Journal of Pharmacology, 1970
• Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase
  Nature, 1967
• The mechanism of action of anticonvulsants II. acetazolamide
  Life Sciences, 1966
• Inhibition of dopa decarboxylase by the hydrazino analog of α-methyldopa
  Biochemical Pharmacology, 1962
• In‐Vivo Decarboxylation of α‐Methyl DOPA and α‐Methyl Metatyrosine
  Acta Physiologica Scandinavica, 1962
• USE OF MOVING AVERAGES AND INTERPOLATION TO ESTIMATE MEDIAN-EFFECTIVE DOSE
  Microbiology and Molecular Biology Reviews, 1947